Suspend bidding to evaluate all the facts.

Congress should suspend the competitive bidding program for diabetes supplies while investigating the increased hospitalization and mortality associated with the project. That evaluation should track both a study and control arm overtime to determine the full impact of diabetes cost, including testing supplies, hospitalization, and outcomes. ACT NOW


Medicare created a competitive bidding program, at Congress’ instruction, to save cost on durable medical equipment. Diabetes testing supplies were included. Medicare tested the program in nine cities. Medicare reported that the program saved money without adverse outcomes.


But there may be things that report didn’t cover. A study of Medicare’s data done by the National Minority Quality Forum shows patient issues that Medicare did not report. These disruptions include higher hospitalizations and complications that cost Medicare more that the bidding program saved. More distressing the evidence shows higher mortality in the test markets.


Congress should investigate to ensure patient safety and make sure that the program to save does not indeed cost us all more. People with diabetes can help by calling on Congress to Investigate.


National Minority Quality Forum Full Report, November 13, 2015.


Press Release: Is Medicare Increasing Mortality Among Seniors?


American Association of Clinical Endocrinologists (AACE)
Letter to Senate Finance Committee December 14, 2015.


Endocrinology Advisor, June 18, 2015: CMS Competitive Bidding Hurts Medicare Beneficiaries With Diabetes


Press Release: Disruption in Access to Diabetes Monitoring Supplies Leads to Increased Hospitalizations, Mortality Among Medicare Beneficiaries

ADA Poster

ADA Fact Sheet

AACE Poster

AACE Fact Sheet



Video on Competitive Bidding

Medicare Beneficiaries and Self-Monitoring of Blood Glucose

Impact of CMS Bidding on Medicare Beneficiaries

CMS Goals for Bidding


ACT NOW: to ask Congress to investigate. Click here to send a letter from the Diabetes Patient Advocacy Coalitions advocacy site.


Who, What, Where, When How


People with Diabetes who use insulin and test strips may be at risk due to Medicare Competitive bidding according to a recent study.


The report shows higher hospitalizations, cost, and mortality


Medicare tested in the program in;

Charlotte-Gastonia-Concord (North Carolina and South Carolina)

Cincinnati-Middletown (Ohio, Kentucky, and Indiana)

Cleveland-Elyria-Mentor (Ohio)

Dallas-Fort Worth-Arlington (Texas)

Kansas City (Missouri and Kansas)

Miami-Fort Lauderdale-Pompano Beach (Florida)

Orlando (Florida)

Pittsburgh (Pennsylvania)

Riverside-San Bernardino-Ontario (California)


It has since rolled it out nationally.


The markets were tested in 2011, and the program has been rolled out nationally


You can act now with this easy link to ask Congress to investigate with this Diabetes Patient Advocacy Coalition letter. It takes just a few seconds.







Usernames and #hashtags



@DiabetesPAC – The DAPC ScoreCard has every Congress member’s Twitter handle [Link] [add tweets to basic scorecard]






Sample Tweets:

#CMS claims no disruption of access to #diabetes testing supplies. @NMQF #whitepaper shows different- Who’s right? /


Increased mortality, hospitalizations & costs? #CMS should be held to same safety standards as clinical trials?


Who do I trust to stay safe with #diabetes? #CMS or the scientists who said there’s a serious problem with bidding: